Ocata Therapeutics Inc news

   Watch this stock
Showing stories 1 - 10 of about 91   

Articles published

OCAT 4.23
price chart
Ocata Therapeutics Appoints Dr. Brian Levy to its Board of Directors
MARLBOROUGH, Mass.--(BUSINESS WIRE)--Ocata Therapeutics, Inc. (NASDAQ:OCAT), a leader in the field of Regenerative Ophthalmology™, today announced that Brian Levy, O.D.
Latest News Updates: Ocata Therapeutics Inc (NASDAQ:OCAT)
Ocata Therapeutics Inc (NASDAQ:OCAT) yesterday reported that it has been awarded a Small Business Innovation Research (SBIR) Phase 1 grant from the National Institute of Allergy and Infectious Diseases (NIAID), part of the National Institutes of Health ...
Mid-Day Changers: Ocata Therapeutics, Inc. (OCAT), Epizyme, Inc. (EPZM ...  WallStreet Scope
Ocata Gevo, and Spherix... Three Stocks Actually Going Higher (OCAT, SPEX, GEVO)  SmallCap Network
Is Ocata Therapeutics' Lackluster Debut A Buy Or Sell? (OCAT)
Ocata Therapeutics (NASDAQ:OCAT), formerly named Advanced Cell Technology underwent a major transformation in a short period of time in all aspects of their business.
Biotech Stocks to bet on: Ocata Therapeutics Inc (NASDAQ:OCAT), Tobira ...
They say good things come in threes. If so, biotech companies could be in for not just another year of outperformance, but another decade.
Ocata Therapeutics Secures $10MM From Silicon Valley Bank  ABL Advisor
Pre-Market News Alert on: Real Goods Solar, - Class A (NASDAQ:RGSE ...  wsnewspublishers
Ocata Therapeutics (OCAT) Stock Declines After Pricing $30 Million Share Offering
"We rate OCATA THERAPEUTICS INC (OCAT) a SELL. This is based on the dominance of unfavorable investment measures, which should drive this stock to significantly underperform the majority of stocks that we rate.
Midday Watch: Rock Creek (RCPI), Ocata Therapeutics (OCAT), Juno (JUNO ...  Wall Street Pit
Ocata Therapeutics to Ring the NASDAQ Stock Market Opening Bell on June 24, 2015  MarketWatch
Advanced Cell Technology Changes Name to Ocata Therapeutics
MARLBOROUGH, Mass.--(BUSINESS WIRE)--Advanced Cell Technology, Inc., (OTCBB: OCAT) today announced the change of its company name to Ocata Therapeutics, Inc., effective immediately. The change, which has been approved by the Company's ...
Related articles »  
Cowen Has Initiated Coverage on Ocata Therapeutics Inc (OTC:OCAT) Stock with ...
The new coverage is well-received by investors, as OTC:OCAT is currently trading 2.76% higher at $5.22 as of 05:06 New York time. Ocata Therapeutics Inc shares have declined -33.84% in the last 200 days, while the Standard & Poor's 500 index has gained ...
Ocata Therapeutics Research Coverage Started at Cowen and Company (OCAT)  WKRB News
Ocata Therapeutics Successfully Completes Dosing in Phase 1/2 RPE Studies
Ocata Therapeutics, Inc. is a clinical stage biotechnology company focused on the development and commercialization of regenerative ophthalmology therapeutics.
Ocata Therapeutics Provides Corporate Update for the Second Quarter of 2015
Ocata Therapeutics, Inc. is a clinical stage biotechnology company focused on the development and commercialization of Regenerative Ophthalmology therapeutics.
Ocata Therapeutics To Trade On Nasdaq Global Market: Can The Bulls Finally ...
After months, if not years for some, Ocata shareholders were pleasantly surprised by the after-hours filing of the Form 8-A on February 23, 2015 by Ocata Therapeutics (NASDAQ:OCAT), which provides for registration of certain classes of securities ...
Ocata Therapeutics Receives Two New Patents for Immune-modulatory Cell ...  MarketWatch
Ocata Therapeutics Inc (OTCMKTS:OCAT) Is Rewarded With Two New Immune ...  Traders350